ENTITY
Lonza Group AG

Lonza Group AG (LONN VX)

37
Analysis
Health Care • Switzerland
Lonza Group AG produces organic fine chemicals, biocides, active ingredients, and biotechnology products. The Company offers custom chemical manufacturing and fermentation processing and manufactures its products for the life sciences, pharmaceuticals, food processing, and agricultural products industries. Lonza operates production sites in Europe, the United States, and China.
more
bullish•Samsung Biologics
•10 Nov 2016 06:20

Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction

As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....

Logo
404 Views
Share
bullish•Samsung Biologics
•01 Nov 2016 18:11

Samsung BioLogics IPO - Why Investors Are Excited & Concerned

Samsung BioLogics will have a big day tomorrow. Nov 2-3 will be the subscription day. The company has already had a huge success with the...

Logo
429 Views
Share
bearish•Samsung Biologics
•21 Oct 2016 06:54

3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week

Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....

Logo
348 Views
Share
bearish•Samsung Biologics
•05 Oct 2016 12:01

Samsung BioLogics IPO Part 3 - Valuation

Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...

Logo
450 Views
Share
bearish•Samsung Biologics
•18 Aug 2016 01:57

Samsung BioLogics IPO Valuation Debate

Samsung BioLogics, Samsung Group's contract manufacturing organization (CMO) of bio logic drugs, is expected to seek preliminary approval from...

Logo
444 Views
Share
x